Details for New Drug Application (NDA): 213665
✉ Email this page to a colleague
The generic ingredient in FLUCYTOSINE is flucytosine. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the flucytosine profile page.
Summary for 213665
Tradename: | FLUCYTOSINE |
Applicant: | Aurobindo Pharma Ltd |
Ingredient: | flucytosine |
Patents: | 0 |
Suppliers and Packaging for NDA: 213665
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FLUCYTOSINE | flucytosine | CAPSULE;ORAL | 213665 | ANDA | Aurobindo Pharma Limited | 59651-331 | 59651-331-01 | 100 CAPSULE in 1 BOTTLE (59651-331-01) |
FLUCYTOSINE | flucytosine | CAPSULE;ORAL | 213665 | ANDA | Aurobindo Pharma Limited | 59651-332 | 59651-332-01 | 100 CAPSULE in 1 BOTTLE (59651-332-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
Approval Date: | May 1, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 500MG | ||||
Approval Date: | May 1, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription